NCT04801043 - To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

January 31, 2022

Conditions

Bacterial Infections

Interventions

DRUG

XNW4107

XNW4107 250mg IV over 60 minutes as a single dose

DRUG

Imipenem/Cilastatin

500mg/500mg IV over 60 minutes as a single dose

DRUG

placebo

"Matching placebo to XNW4107 containing the same inactive ingredients IV over 60 minutes as a single dose~Matching placebo to Imipenem/Cilastatin 0.9% sodium chloride IV over 60 minutes as a single dose"

Trial Locations (1)

32809-3017

Orlando Clinical Research Center (OCRC), Orlando